In dMMR/MSI-H CRC, genetic alterations of the APM are commonly observed: 11% of untreated primary tumor samples show a loss of the β2M gene, and 55% exhibit alterations within the APM [51]. This evidence concerns the gene B2M and colorectal carcinoma.